Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.8 USD | -1.77% | +13.31% | 0.00% |
May. 15 | Oppenheimer Adjusts PACS Group Price Target to $32 From $31, Maintains Outperform Rating | MT |
May. 15 | RBC Raises Price Target on PACS Group to $32 From $30, Keeps Outperform Rating | MT |
Financials (USD)
Sales 2024 * | 3.73B | Sales 2025 * | 4.26B | Capitalization | 4.25B |
---|---|---|---|---|---|
Net income 2024 * | 208M | Net income 2025 * | 279M | EV / Sales 2024 * | 1.16 x |
Net Debt 2024 * | 91.3M | Net cash position 2025 * | 129M | EV / Sales 2025 * | 0.97 x |
P/E ratio 2024 * |
20.1
x | P/E ratio 2025 * |
15.5
x | Employees | 32,433 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 11.76% |
1 day | -0.18% | ||
1 week | +13.88% | ||
Current month | +13.34% | ||
1 month | +16.94% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 28.18 | -0.42% | 18 432 |
24-05-16 | 28.3 | -0.18% | 320,812 |
24-05-15 | 28.35 | +5.35% | 635,811 |
24-05-14 | 26.91 | +7.30% | 532,250 |
24-05-13 | 25.08 | +0.84% | 286,580 |
Delayed Quote Nyse, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 4.25B | |
+19.22% | 84.52B | |
-27.14% | 72.21B | |
+4.65% | 27.74B | |
-6.23% | 17.97B | |
+0.71% | 17.46B | |
+3.30% | 15.82B | |
+7.44% | 13.55B | |
+6.30% | 13.31B | |
+73.32% | 13.32B |
- Stock Market
- Equities
- PACS Stock